Prenatal diagnosis for thalassaemia in Egypt: What changed parents' attitude?

Prenatal Diagnosis

Volumn 32, Issue 8, 2012, Pages 777-782

  El Beshlawy, A ^a   El Shekha, A ^a   Momtaz, M ^a   Said, F ^a   Hamdy, M ^a   Osman, O ^a   Meshaal, S ^a   Gafaar, T ^a   Petrou, M ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ARTICLE; DOT HYBRIDIZATION; EGYPT; FEMALE; FETUS; HLA MATCHING; HLA TYPING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARENTAL ATTITUDE; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; THALASSEMIA;

ABORTION, INDUCED; ATTITUDE; CHORIONIC VILLI SAMPLING; EGYPT; FEMALE; HUMANS; ISLAM; PREGNANCY; THALASSEMIA;

EID: 84864295336     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3901     Document Type: Article

References (36)

1. El-Beshlawy A, Kaddah N, Mostafa A, et al. Screening for β-thalassemia carriers in Egypt: Significance of the osmotic fragility test. East Mediterr Health J 2007;13(4):780-6.
2. Novelletto A, Hafez M, Deidda G, et al. Molecular characterization of β thalassemia mutations in Egypt. Hum Genet 1990;85:272-4.
3. Loukopoulos D, Rombou D, Panourgias J, et al. Prenatal diagnosis of thalassemia and Hb S syndromes in Greece: an evaluation of 1500 cases. Ann NY Acad Sci 1985;445:357-75.
4. Loukopoulos D. Current status of thalassaemia and the sickle cell syndromes in Greece. Seminars Hematol 1996;33:76-86.
5. Angastiniotis MA, Kyriakidou S, Hadjiminas M. How thalassaemia was controlled in Cyprus. World Health Forum 1986;7:291-7.
6. Cao A, Furbetta M, Galanello R, et al. Prevention of homozygous B-thalassaemia by carrier screening and prenatal diagnosis in Sardinia. Am J Hum Genet 1981;33:592-605.
7. Cao A, Rosatelli C, Galanello R, et al. The prevention of thalassemia in Sardinia. Clin Genet 1989;36:277-85.
8. Maggio A, Caronia F, Orlandi F. Prenatal diagnosis of haemoglobinopathies in Sicily. Lancet 1992;339:1361-2.
9. Huisman TH, Carver MF. The beta and delta thalassemia repository (Ninth Edition; Part 1). Hemoglobin 1998;22(2):169-95.
10. Hardison RC, Chui DH, Giardine B, et al. Hb variants: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002;19(3):225-33.
11. Hussein IR, Temtamy SA, El-Beshlawy A, et al. Molecular characterization of beta-thalassemia in Egyptians. Hum Mutat 1993;2(1):488-452.
12. El-Gawhary S, El-Shafie S, Niazi M, et al. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients. Hemoglobin 2007;31(1):63-9.
13. El Beshlawy A, Youssry I. Prevention of Hemoglobinopathies in Egypt. Hemoglobin 2009;33 (1):S14-20.
14. El Gawhary S, El Baradie Sahar MY, Rashad WM, et al. Prenatal diagnosis of beta-thalassemia in Egypt: implementing accurate high-tech methods did not reflect much on the outcome. Pediatr Hematol Oncol 2008;25(6):541-8.
15. Hussein IR, El-Beshlawy A, Gaber KR. Prenatal Diagnosis of beta-thalassemia in Egypt. Egyptian J Hematol 2000;25:547-61.
16. Jauniaux E, Petrou M. Fetal sampling for the Haemoglobin Disorders. Prevention of thalassaemia and other haemoglobin disorders. Volume 1. Thalassaemia International Federation Publications (3), 2003. ISBN 9963-623-39-5.
17. Georgiou I, Makis A, Chaidos A, Bouba I, Hatzi E, Kranas V, Zilidis C, Bourantas KL. Distribution and frequency of β-thalassemia mutations in northwestern and central Greece. Eur J Haematol 2003;70:75-8.
18. Soliman OE, Yahia S, Shouma A, Shafiek HK, Fouda AE, Azzam H, Abousamra NK, Mahfouz R, Goda EF, El-Sharawy SA. Reverse hybridization StripAssay detection of β-thalassemia mutations in northeast Egypt. Hematology 2010;15(3):182-6.
19. Old J, Petrou M, Varnavides L, et al. Accuracy of prenatal diagnosis for hemoglobin disorders in the UK: 25 years' experience. Prenat Diagn 2000;20(12):986-91.
20. Batanian JR, Ledbetter DH, Fenwick RG. Simple VNTR- PCR Method for detecting maternal cell contamination in prenatal diagnosis. Genet Test 1998:347-50.
21. El Hashemite N, Petrou M, Califa AS, et al. Identification of novel Asian Indian and Japanese mutations causing β-thalassemia in the Egyptian population. Hum Genet 1997;99:271-4.
22. Hussein IR, Temtamy SA, El Beshlawy A, et al. Screening for β-thalassemia mutations in Egypt by reverse dot blot hybridization. Egypt J Genet Cytol 1997;26:261-71.
23. Jiffri EH, Bogari N, Zidan KH, et al. Molecular updating of β thalassemia mutations in the Upper Egyptian population. Hemoglobin 2010;34(6):538-47.
24. Hussein G, Fawzy M, Serafi TE, et al. Rapid detection of beta thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hemoglobin 2007;31(1):49-62.
25. Petrou M. Genetic Counselling. Prevention of thalassaemia and other haemoglobin disorders. Volume 1. Thalassaemia International Federation Publications (3), 2003. ISBN 9963-623-39-5.
26. El-Hazmi M. Ethical issues on prevention and management of blood genetics disorder-Islamic views. Hemoglobin 2009;33(S1):S1-6.
27. Fletcher JC, Berg K, Tranoy KE. Ethical aspects of medical genetics: a proposal for guidelines in genetic counselling, prenatal diagnosis and screening. Clin Genet 1985;27:199-205.
28. Alkuraya FS, Kilani RA. Attitude of Saudi families affected with hemoglobinopathies towards prenatal screening and abortion and the influence of religious ruling (Fatwa). Prenat Diagn 2001;21(6):448-51.
29. Ahmed S, Atkin K, Hewison J, Green J. The Influence of Faith and religion and the role of religious and community leaders in prenatal decisions for sickle cell disorders and thalassemia major. Prenat Diagn 2006;26(9):801-9.
30. Ahmed S, Green JM, Hewison J. Attitudes towards prenatal diagnosis and termination of pregnancy for thalassaemia in pregnant Pakistani women in the North of England. Prenat Diagn 2006;26(3):248-57.
31. Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004;329:1134-7.
32. Alwan AA, Modell B. Community Control of Genetic and Congenital Disorders. EMRO Technical Publications Series 24. World Health Organisation Regional Office for the Eastern Mediterranean, 1997;218. ISBN 92-9021-220-9. ISSN 1020-0428. ISSN 1020-0428
33. Petrou B, Modell B, Shetty S, Ward RHT Long-term effects of prospective detection of high genetic risk on couples' reproductive life: data for thalassaemia. Prenat Diagn 2000;20:469-74.
34. Cao A, Rosatelli Screening and prenatal diagnosis of the haemoglobinopathies. Balliere Clin Haematol. 1993;6:263-86.
35. Kanathezhath B, Walters MC. Umbilical cord blood transplantation for thalassemia major. Hematol Oncol Clin North Am 2010;24 (6):1156-77.
36. Boncimino A, Bertaina A, Locatelli F. Cord blood transplantation in patients with hemoglobinopathies. Transfus Aspher Sci 2010;42(3):277-81.